Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Hughes

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|December 3, 1999
Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogeneticsS Branford, T P Hughes, Z Rudzki
Leukemia|February 12, 2010
Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cellsL Eadie, T P Hughes, D L White
Leukemia & Lymphoma|June 1, 2000
Stem cell factor and chronic myeloid leukemia CD34+ cellsS Moore, L A McDiarmid, T P Hughes
Ecology|November 21, 2017
Large-scale bleaching of corals on the Great Barrier ReefT P Hughes, J T Kerry, T Simpson
Arthritis and Rheumatism|June 1, 1989
Hypergammaglobulinemia and the anticardiolipin antibody testT P Hughes, P Jones, M C Rozenberg
Trends in Ecology & Evolution|January 18, 2011
The evolutionary ecology of coralsT P Hughes, D Ayre, J H Connell
Clinical Pharmacology and Therapeutics|February 25, 2011
OCT-1 as a determinant of response to antileukemic treatmentJ R Engler, T P Hughes, D L White
Leukemia|September 17, 2010
Do we have to kill the last CML cell?D M Ross, T P Hughes, J V Melo
Leukemia|December 3, 2016
Response to 'Overexpression of ABCB1 as prediction marker for CML: How close we are to translation into clinics?'L N Eadie, T P Hughes, D L White
The Journal of Experimental Medicine|October 30, 2009
THE EPIDEMIOLOGY OF FOWL CHOLERA : V. FURTHER FIELD OBSERVATIONS OF THE SPONTANEOUS DISEASEI W Pritchett, F R Beaudette, T P Hughes
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|December 3, 1999
Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogeneticsS Branford, T P Hughes, Z Rudzki
Leukemia|February 12, 2010
Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cellsL Eadie, T P Hughes, D L White
Leukemia & Lymphoma|June 1, 2000
Stem cell factor and chronic myeloid leukemia CD34+ cellsS Moore, L A McDiarmid, T P Hughes
Ecology|November 21, 2017
Large-scale bleaching of corals on the Great Barrier ReefT P Hughes, J T Kerry, T Simpson
Arthritis and Rheumatism|June 1, 1989
Hypergammaglobulinemia and the anticardiolipin antibody testT P Hughes, P Jones, M C Rozenberg
Trends in Ecology & Evolution|January 18, 2011
The evolutionary ecology of coralsT P Hughes, D Ayre, J H Connell
Clinical Pharmacology and Therapeutics|February 25, 2011
OCT-1 as a determinant of response to antileukemic treatmentJ R Engler, T P Hughes, D L White
Leukemia|September 17, 2010
Do we have to kill the last CML cell?D M Ross, T P Hughes, J V Melo
Leukemia|December 3, 2016
Response to 'Overexpression of ABCB1 as prediction marker for CML: How close we are to translation into clinics?'L N Eadie, T P Hughes, D L White
The Journal of Experimental Medicine|October 30, 2009
THE EPIDEMIOLOGY OF FOWL CHOLERA : V. FURTHER FIELD OBSERVATIONS OF THE SPONTANEOUS DISEASEI W Pritchett, F R Beaudette, T P Hughes
Pageof 13